SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Iovance Reports Durable Lifileucel Responses in Soft Tissue Sarcomas

Iovance reported a 50% confirmed objective response rate, with all responses ongoing. The data were presented at ESMO 2026.

IOVA

Related stories